The first theranostic: EAA™ & Toraymyxin

Spectral is pleased to welcome the University of Virginia as the newest site to participate in the Tigris clinical trial.



Spectral Announces First Quarter Results and Provides Corporate Update

Tigris Trial Enrollment Reaches 106 Patients
Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment

May 13, 2024

Spectral Medical Provides April Tigris Trial Update

105 patients enrolled April represents a record breaking month for patient enrollment  TORONTO, Canada – May 6, 2024 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...

read more

2024 AGM presentation

Annual General Meeting of Shareholder Presentation June 2024

Spectral Tigris Trial and Corporate Update Replay

February 2024

crrt conference 2024 REPLAY

CRRT Conference Breakfast Symposium
Waking up to Endotoxemic Septic Shock. What do you need to be ready?
Wednesday March 13, 2024
San Diego, CA

Moderators: John Kellum and Debra Foster
Diagnosing ESS in the real world – Danielle Davison, George Washington University
Treating ESS in the real world – Javier Neyra, University of Alabama
Implementing PMX hemoadsorption at the bedside – Johann Chang, (Spectral), Tara Morgan-Gray, (Colorado Springs)

the balancing act on lifetime tv

Endotoxic Septic Shock  as featured on The Balancing Act on Lifetime TV.